ENTOD Pharmaceuticals on Thursday announced that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for PresVu to treat age-related vision impairment.
Entod Pharmaceuticals has announced the launch of Cyclotears eye drops in India and its various global markets for patients with inflammatory dry eye disease (DED), a commonly occurring condition.
To further expand their business, pharmaceutical giant — Entod Pharmaceuticals is all set to launch its GLO division. This one-of-a-kind ophthalmic subspeciality division is focused on the treatment of the eye condition glaucoma, which is a leading cause of irreversible blindness in India. This comes after due consideration that awareness and timely treatment to deter the progress of glaucoma is the need of the hour.
To further expand their business, pharmaceutical giant Entod Pharmaceuticals is all set to launch its GLO division. This one-of-a-kind ophthalmic subspeciality division is focused on the treatment of the eye condition glaucoma, which is a leading cause of irreversible blindness in India. This comes after due consideration that awareness and timely treatment to deter the progress of glaucoma is the need of the hour.
New Delhi: Entod Pharmaceuticals announced that it is in the final stages of developing an eye drop that could change the lives of millions with age-related blu ..
Entod has launched its facial gel serum “Vasuki” in India yesterday. The serum is one of the world’s first clinically-proven synthetic tripeptidesnake venom neurotoxin developed by the advanced skincare laboratories of Entod Research Cell UK.
New Delhi: ENTOD Pharmaceuticals which specialises in ophthalmic, ENT and dermatology medicines is eyeing sales of more than half a million strips of Macushield tablets in 2022.